Low-dose buccal buprenorphine: Relative abuse potential and postoperative analgesic acceptability
低剂量含服丁丙诺啡:相对滥用潜力和术后镇痛可接受性
基本信息
- 批准号:10572350
- 负责人:
- 金额:$ 17.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-03-15 至 2028-02-29
- 项目状态:未结题
- 来源:
- 关键词:Absence of pain sensationAcute PainAddressAdverse effectsAmericanAnalgesicsAuthorization documentationBiometryBuprenorphineCaringCessation of lifeChadClinicalClinical InvestigatorClinical SciencesClinical Trials DesignCrossover DesignDataDevelopmentDevelopment PlansDiagnosisDoseDrug PrescriptionsDrug abuseEnrollmentEuphoriaExposure toFDA approvedFormulationFriendsFundingIatrogenesisIntravenousJournalsKnowledgeLearningLightMentorsObservational StudyOperative Surgical ProceduresOpioidOpioid agonistOralOverdoseOxycodonePainPain managementParticipantPatientsPatternPharmaceutical PreparationsPharmacodynamicsPhenotypePhysiciansPlacebosPositioning AttributePositive ReinforcementsPostoperative PainPostoperative PeriodPsychophysicsPsychosocial FactorPublicationsRandomizedRandomized, Controlled TrialsReportingResearch TrainingRiskSeminalSensoryShapesSpecialistStandardizationTestingTrainingTranslational ResearchUnited States National Institutes of HealthVentilatory DepressionVeteransWorkabuse liabilityacceptability and feasibilityantagonistauthoritycareercareer developmentchronic painclinical databaseclinical paindesigndisorder riskexperiencefeasibility testingfollow-upindexinginsightmu opioid receptorsopioid abuseopioid misuseopioid mortalityopioid overdoseopioid useopioid use disorderoverdose riskparticipant enrollmentprescription opioidprescription opioid misusepsychosocialrandomized, clinical trialsresponserisk/benefit ratioskillstranslational scientisttranslational study
项目摘要
ABSTRACT
About 25% of the 69,710 U.S. opioid overdose deaths in 2020 involved prescription opioids directly, and many
of the remaining overdose victims started opioid use with prescribed medication. Post-surgical opioid
prescribing comprises an increasing share of opioid prescribing, with considerable risks for misuse, new
persistent opioid use (NPOU), and opioid use disorder (OUD). There is a need to decrease these iatrogenic
risks without compromising postoperative analgesia. Buccal buprenorphine represents a potential alternative to
traditional post-surgical opioid prescribing with known lower respiratory depression risk. However, minimal data
exists regarding whether its administration yields: (1) decreased abuse potential or (2) acceptable analgesia for
acute pain. The Research Training Plan addresses these key gaps in understanding regarding the risk/benefit
ratio of postoperative buccal buprenorphine. Aim 1 involves pharmacodynamic and psychophysical
assessment of abuse potential and analgesia following buccal buprenorphine administration in a controlled
experimental setting. Aim 2 entails a preliminary study assessing the feasibility and acceptability of a
randomized clinical trial of prescribing buccal buprenorphine for postoperative pain management. In each aim,
buccal buprenorphine will be compared with oxycodone, a commonly prescribed postoperative opioid. The
candidate has prior experience with small observational studies and large clinical database studies related to
post-surgical opioids and pain, with several first- and co-first-author publications in major journals. The Career
Development Plan will allow him to gain new proficiencies in the assessment of abuse potential and pain as
well as clinical trial design and execution, biostatistics, grantsmanship, and professional development. Mentor
Dr. Stephen Bruehl specializes in the experimental assessment of the subjective and analgesic response to
opioid administration. Co-mentor Dr. Sharon Walsh performed the seminal studies on buprenorphine
pharmacodynamics and is an expert on OUD. Co-mentors Dr. Chad Brummett and Dr. David Edwards are
authorities on postoperative opioid prescribing, and co-mentor Dr. Benjamin French is a specialist in clinical
trial design and biostatistics. Vanderbilt’s setting is highly conducive to research training and implementation.
This project will set the candidate on course for a career as an independent translational and clinical
investigator. The proposed studies promise to offer insights into whether buccal buprenorphine can serve as
an alternative postoperative analgesic with lower abuse potential. The subsequent planned definitive trial could
reshape post-surgical opioid prescribing patterns.
摘要
2020年,美国69,710例阿片类药物过量死亡中约有25%直接涉及处方阿片类药物,许多
其余的过量受害者开始使用阿片类药物与处方药。术后阿片类药物
处方包括越来越多的阿片类药物处方,滥用风险相当大,新
持续性阿片类药物使用(NPOU)和阿片类药物使用障碍(OUD)。有必要减少这些医源性
不影响术后镇痛。口含丁丙诺啡是一种潜在的替代药物,
传统的术后阿片类药物处方与已知的下呼吸抑制风险。然而,最少的数据
存在关于其施用是否产生:(1)降低的滥用可能性或(2)可接受的镇痛,
剧烈疼痛。研究培训计划解决了对风险/获益理解方面的这些关键差距
术后颊含丁丙诺啡的比例。目的1涉及药效学和心理物理学
在对照组中评估含服丁丙诺啡后的滥用可能性和镇痛作用
实验设置。目标2需要进行初步研究,评估一项
开口腔丁丙诺啡用于术后疼痛管理的随机临床试验。在每一个目标中,
口含丁丙诺啡将与羟考酮(一种常用的术后阿片类药物)进行比较。的
候选人之前有小型观察性研究和大型临床数据库研究的经验,
手术后阿片类药物和疼痛,在主要期刊上发表了几篇第一作者和共同第一作者的论文。职业
发展计划将使他在评估滥用潜力和痛苦方面获得新的专业知识,
以及临床试验设计和执行、生物统计学、粒度分析和专业发展。导师
博士Stephen Bruehl专门从事主观和镇痛反应的实验评估,
阿片类药物给药。共同导师Sharon沃尔什博士进行了丁丙诺啡的开创性研究
药效学,是OUD的专家。Chad Brummett博士和大卫爱德华兹博士是
术后阿片类药物处方的权威,共同导师本杰明·弗伦奇博士是一位临床专家,
试验设计和生物统计学。范德比尔特的环境非常有利于研究培训和实施。
该项目将设置候选人的职业生涯作为一个独立的翻译和临床
调查员拟议的研究承诺提供深入了解是否颊丁丙诺啡可以作为
一种具有较低滥用可能性的替代术后镇痛药。随后计划的最终审判可能
重塑术后阿片类药物处方模式。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Daniel Larach其他文献
Daniel Larach的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Clinical Outcome Assessments for Acute Pain Therapeutics in Infants and young Children (COA APTIC)
婴幼儿急性疼痛治疗的临床结果评估 (COA APTIC)
- 批准号:
10778757 - 财政年份:2023
- 资助金额:
$ 17.56万 - 项目类别:
Selective actin remodeling of sensory neurons for acute pain management
感觉神经元的选择性肌动蛋白重塑用于急性疼痛管理
- 批准号:
10603436 - 财政年份:2023
- 资助金额:
$ 17.56万 - 项目类别:
Clinical Outcome Assessments for Acute Pain Therapeutics in Infants and young Children (COA APTIC)
婴幼儿急性疼痛治疗的临床结果评估 (COA APTIC)
- 批准号:
10783106 - 财政年份:2023
- 资助金额:
$ 17.56万 - 项目类别:
Development of A Focused Ultrasound Device for Noninvasive, Peripheral Nerve Blockade to Manage Acute Pain
开发用于非侵入性周围神经阻断来治疗急性疼痛的聚焦超声装置
- 批准号:
10740796 - 财政年份:2023
- 资助金额:
$ 17.56万 - 项目类别:
Predicting Pediatric Sickle Cell Disease Acute Pain Using Mathematical Models Based on mHealth Data
使用基于移动健康数据的数学模型预测儿童镰状细胞病急性疼痛
- 批准号:
10599401 - 财政年份:2022
- 资助金额:
$ 17.56万 - 项目类别:
Non-Contingent Acute Pain Stress Drives Analgesic Protection in Rats.
非偶然急性疼痛应激驱动大鼠镇痛保护。
- 批准号:
575854-2022 - 财政年份:2022
- 资助金额:
$ 17.56万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Master's
Prefrontal Cortex Hemodynamic Responses to Mindfulness Meditation and Acute Pain
前额皮质血流动力学对正念冥想和急性疼痛的反应
- 批准号:
467076 - 财政年份:2021
- 资助金额:
$ 17.56万 - 项目类别:
Studentship Programs
A Multimodal Approach for Monitoring Prolonged Acute Pain in Neonates
监测新生儿长期急性疼痛的多模式方法
- 批准号:
9979265 - 财政年份:2020
- 资助金额:
$ 17.56万 - 项目类别:
A Multimodal Approach for Monitoring Prolonged Acute Pain in Neonates
监测新生儿长期急性疼痛的多模式方法
- 批准号:
10218273 - 财政年份:2020
- 资助金额:
$ 17.56万 - 项目类别: